世界のムスカリン性アセチルコリン受容体M4市場2020:製造企業別、地域別、種類別、用途別、市場予測2025

GlobalInfoResearchが発行した調査報告書(GIR20OC06792)
◆英語タイトル:Global Muscarinic Acetylcholine Receptor M4 Market 2020 by Manufacturers, Regions, Type and Application, Forecast to 2025
◆商品コード:GIR20OC06792
◆発行会社(リサーチ会社):GlobalInfoResearch
◆発行日:2020年10月(※2024年版があります。お問い合わせください。)
◆ページ数:104
◆レポート形式:英語 / PDF
◆納品方法:Eメール
◆調査対象地域:グローバル
◆産業分野:医薬品・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD3,480 ⇒換算¥515,040見積依頼/購入/質問フォーム
Multi User(10名様閲覧用)USD5,220 ⇒換算¥772,560見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalInfoResearch社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。GlobalInfoResearch社の概要及び新刊レポートはこちらでご確認いただけます。

本書では、ムスカリン性アセチルコリン受容体M4の世界市場を調査対象にし、ムスカリン性アセチルコリン受容体M4の市場概要、メーカー情報、メーカー別販売量・売上・市場シェア、地域別市場分析(北米、アメリカ、ヨーロッパ、アジア、日本、中国、南米、中東・アフリカ)、種類別分析(トロピカミド、ANAVEX-273、VU-0467154、その他)、用途別分析(認知障害、精神病、健忘、その他)、市場予測(2021年~2025年)、販売チャンネル・代理店分析情報などを整理しました。
・市場概要
・メーカー情報:Anavex Life Sciences Corp、Karuna Pharmaceuticals Inc、AstraZeneca Plc、Heptares Therapeutics Ltd、Sumitomo Dainippon Pharma Co Ltd、NeuroHealing Pharmaceuticals Inc
・メーカー別販売量、売上、市場シェア
・ムスカリン性アセチルコリン受容体M4の地域別市場分析
・ムスカリン性アセチルコリン受容体M4の北米市場規模2015-2020:アメリカ、カナダ、メキシコ
・ムスカリン性アセチルコリン受容体M4のヨーロッパ市場規模2015-2020:ドイツ、イギリス、フランス、ロシアなど
・ムスカリン性アセチルコリン受容体M4のアジア市場規模2015-2020:日本、中国、韓国、インド、東南アジアなど
・ムスカリン性アセチルコリン受容体M4の南米市場規模2015-2020:ブラジル、アルゼンチンなど
・ムスカリン性アセチルコリン受容体M4の中東・アフリカ市場規模2015-2020:サウジアラビア、トルコ、エジプト、南アフリカなど
・ムスカリン性アセチルコリン受容体M4の種類別市場規模2015-2020:トロピカミド、ANAVEX-273、VU-0467154、その他
・ムスカリン性アセチルコリン受容体M4の用途別市場規模2015-2020:認知障害、精神病、健忘、その他
・ムスカリン性アセチルコリン受容体M4の世界市場予測2021-2025:地域別、種類別、用途別
・販売チャンネル・代理店分析
・調査の結果・結論
【レポートの概要】

Market Overview
The global Muscarinic Acetylcholine Receptor M4 market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.

The Muscarinic Acetylcholine Receptor M4 market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

Market segmentation
Muscarinic Acetylcholine Receptor M4 market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

By Type, Muscarinic Acetylcholine Receptor M4 market has been segmented into
Tropicamide
ANAVEX-273
VU-0467154
Others

By Application, Muscarinic Acetylcholine Receptor M4 has been segmented into:
Cognitive Disorders
Psychosis
Amnesia
Others

Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Muscarinic Acetylcholine Receptor M4 market presented in the report. This section sheds light on the sales growth of different regional and country-level Muscarinic Acetylcholine Receptor M4 markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Muscarinic Acetylcholine Receptor M4 market.

The report offers in-depth assessment of the growth and other aspects of the Muscarinic Acetylcholine Receptor M4 market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, etc.)
Middle East & Africa (Saudi Arabia, Egypt, Nigeria and South Africa)

Competitive Landscape and Muscarinic Acetylcholine Receptor M4 Market Share Analysis
Muscarinic Acetylcholine Receptor M4 competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Muscarinic Acetylcholine Receptor M4 sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Muscarinic Acetylcholine Receptor M4 sales, revenue and market share for each player covered in this report.

The major players covered in Muscarinic Acetylcholine Receptor M4 are:
Anavex Life Sciences Corp
Karuna Pharmaceuticals Inc
AstraZeneca Plc
Heptares Therapeutics Ltd
Sumitomo Dainippon Pharma Co Ltd
NeuroHealing Pharmaceuticals Inc

Among other players domestic and global, Muscarinic Acetylcholine Receptor M4 market share data is available for global, North America, Europe, Asia-Pacific, Middle East and Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.

The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Muscarinic Acetylcholine Receptor M4 product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Muscarinic Acetylcholine Receptor M4, with price, sales, revenue and global market share of Muscarinic Acetylcholine Receptor M4 in 2018 and 2019.
Chapter 3, the Muscarinic Acetylcholine Receptor M4 competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Muscarinic Acetylcholine Receptor M4 breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2015 to 2020.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2015 to 2020.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2015 to 2020.
Chapter 12, Muscarinic Acetylcholine Receptor M4 market forecast, by regions, type and application, with sales and revenue, from 2020 to 2025.
Chapter 13, 14 and 15, to describe Muscarinic Acetylcholine Receptor M4 sales channel, distributors, customers, research findings and conclusion, appendix and data source.

【レポートの目次】

Table of Contents

1 Market Overview
1.1 Muscarinic Acetylcholine Receptor M4 Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Muscarinic Acetylcholine Receptor M4 Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Tropicamide
1.2.3 ANAVEX-273
1.2.4 VU-0467154
1.2.5 Others
1.3 Market Analysis by Application
1.3.1 Overview: Global Muscarinic Acetylcholine Receptor M4 Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Cognitive Disorders
1.3.3 Psychosis
1.3.4 Amnesia
1.3.5 Others
1.4 Overview of Global Muscarinic Acetylcholine Receptor M4 Market
1.4.1 Global Muscarinic Acetylcholine Receptor M4 Market Status and Outlook (2015-2025)
1.4.2 North America (United States, Canada and Mexico)
1.4.3 Europe (Germany, France, United Kingdom, Russia and Italy)
1.4.4 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.5 South America, Middle East & Africa
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Anavex Life Sciences Corp
2.1.1 Anavex Life Sciences Corp Details
2.1.2 Anavex Life Sciences Corp Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Anavex Life Sciences Corp SWOT Analysis
2.1.4 Anavex Life Sciences Corp Product and Services
2.1.5 Anavex Life Sciences Corp Muscarinic Acetylcholine Receptor M4 Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.2 Karuna Pharmaceuticals Inc
2.2.1 Karuna Pharmaceuticals Inc Details
2.2.2 Karuna Pharmaceuticals Inc Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Karuna Pharmaceuticals Inc SWOT Analysis
2.2.4 Karuna Pharmaceuticals Inc Product and Services
2.2.5 Karuna Pharmaceuticals Inc Muscarinic Acetylcholine Receptor M4 Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.3 AstraZeneca Plc
2.3.1 AstraZeneca Plc Details
2.3.2 AstraZeneca Plc Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 AstraZeneca Plc SWOT Analysis
2.3.4 AstraZeneca Plc Product and Services
2.3.5 AstraZeneca Plc Muscarinic Acetylcholine Receptor M4 Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.4 Heptares Therapeutics Ltd
2.4.1 Heptares Therapeutics Ltd Details
2.4.2 Heptares Therapeutics Ltd Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Heptares Therapeutics Ltd SWOT Analysis
2.4.4 Heptares Therapeutics Ltd Product and Services
2.4.5 Heptares Therapeutics Ltd Muscarinic Acetylcholine Receptor M4 Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.5 Sumitomo Dainippon Pharma Co Ltd
2.5.1 Sumitomo Dainippon Pharma Co Ltd Details
2.5.2 Sumitomo Dainippon Pharma Co Ltd Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Sumitomo Dainippon Pharma Co Ltd SWOT Analysis
2.5.4 Sumitomo Dainippon Pharma Co Ltd Product and Services
2.5.5 Sumitomo Dainippon Pharma Co Ltd Muscarinic Acetylcholine Receptor M4 Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.6 NeuroHealing Pharmaceuticals Inc
2.6.1 NeuroHealing Pharmaceuticals Inc Details
2.6.2 NeuroHealing Pharmaceuticals Inc Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 NeuroHealing Pharmaceuticals Inc SWOT Analysis
2.6.4 NeuroHealing Pharmaceuticals Inc Product and Services
2.6.5 NeuroHealing Pharmaceuticals Inc Muscarinic Acetylcholine Receptor M4 Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
3 Sales, Revenue and Market Share by Manufacturer
3.1 Global Muscarinic Acetylcholine Receptor M4 Sales and Market Share by Manufacturer (2018-2019)
3.2 Global Muscarinic Acetylcholine Receptor M4 Revenue and Market Share by Manufacturer (2018-2019)
3.3 Market Concentration Rate
3.3.1 Top 3 Muscarinic Acetylcholine Receptor M4 Manufacturer Market Share in 2019
3.3.2 Top 6 Muscarinic Acetylcholine Receptor M4 Manufacturer Market Share in 2019
3.4 Market Competition Trend
4 Global Market Analysis by Regions
4.1 Global Muscarinic Acetylcholine Receptor M4 Sales, Revenue and Market Share by Regions
4.1.1 Global Muscarinic Acetylcholine Receptor M4 Sales and Market Share by Regions (2015-2020)
4.1.2 Global Muscarinic Acetylcholine Receptor M4 Revenue and Market Share by Regions (2015-2020)
4.2 North America Muscarinic Acetylcholine Receptor M4 Sales and Growth Rate (2015-2020)
4.3 Europe Muscarinic Acetylcholine Receptor M4 Sales and Growth Rate (2015-2020)
4.4 Asia-Pacific Muscarinic Acetylcholine Receptor M4 Sales and Growth Rate (2015-2020)
4.5 South America Muscarinic Acetylcholine Receptor M4 Sales and Growth Rate (2015-2020)
4.6 Middle East and Africa Muscarinic Acetylcholine Receptor M4 Sales and Growth Rate (2015-2020)
5 North America by Country
5.1 North America Muscarinic Acetylcholine Receptor M4 Sales, Revenue and Market Share by Country
5.1.1 North America Muscarinic Acetylcholine Receptor M4 Sales and Market Share by Country (2015-2020)
5.1.2 North America Muscarinic Acetylcholine Receptor M4 Revenue and Market Share by Country (2015-2020)
5.2 United States Muscarinic Acetylcholine Receptor M4 Sales and Growth Rate (2015-2020)
5.3 Canada Muscarinic Acetylcholine Receptor M4 Sales and Growth Rate (2015-2020)
5.4 Mexico Muscarinic Acetylcholine Receptor M4 Sales and Growth Rate (2015-2020)
6 Europe by Country
6.1 Europe Muscarinic Acetylcholine Receptor M4 Sales, Revenue and Market Share by Country
6.1.1 Europe Muscarinic Acetylcholine Receptor M4 Sales and Market Share by Country (2015-2020)
6.1.2 Europe Muscarinic Acetylcholine Receptor M4 Revenue and Market Share by Country (2015-2020)
6.2 Germany Muscarinic Acetylcholine Receptor M4 Sales and Growth Rate (2015-2020)
6.3 UK Muscarinic Acetylcholine Receptor M4 Sales and Growth Rate (2015-2020)
6.4 France Muscarinic Acetylcholine Receptor M4 Sales and Growth Rate (2015-2020)
6.5 Russia Muscarinic Acetylcholine Receptor M4 Sales and Growth Rate (2015-2020)
6.6 Italy Muscarinic Acetylcholine Receptor M4 Sales and Growth Rate (2015-2020)
7 Asia-Pacific by Regions
7.1 Asia-Pacific Muscarinic Acetylcholine Receptor M4 Sales, Revenue and Market Share by Regions
7.1.1 Asia-Pacific Muscarinic Acetylcholine Receptor M4 Sales and Market Share by Regions (2015-2020)
7.1.2 Asia-Pacific Muscarinic Acetylcholine Receptor M4 Revenue and Market Share by Regions (2015-2020)
7.2 China Muscarinic Acetylcholine Receptor M4 Sales and Growth Rate (2015-2020)
7.3 Japan Muscarinic Acetylcholine Receptor M4 Sales and Growth Rate (2015-2020)
7.4 Korea Muscarinic Acetylcholine Receptor M4 Sales and Growth Rate (2015-2020)
7.5 India Muscarinic Acetylcholine Receptor M4 Sales and Growth Rate (2015-2020)
7.6 Southeast Asia Muscarinic Acetylcholine Receptor M4 Sales and Growth Rate (2015-2020)
7.7 Australia Muscarinic Acetylcholine Receptor M4 Sales and Growth Rate (2015-2020)
8 South America by Country
8.1 South America Muscarinic Acetylcholine Receptor M4 Sales, Revenue and Market Share by Country
8.1.1 South America Muscarinic Acetylcholine Receptor M4 Sales and Market Share by Country (2015-2020)
8.1.2 South America Muscarinic Acetylcholine Receptor M4 Revenue and Market Share by Country (2015-2020)
8.2 Brazil Muscarinic Acetylcholine Receptor M4 Sales and Growth Rate (2015-2020)
8.3 Argentina Muscarinic Acetylcholine Receptor M4 Sales and Growth Rate (2015-2020)
9 Middle East & Africa by Countries
9.1 Middle East & Africa Muscarinic Acetylcholine Receptor M4 Sales, Revenue and Market Share by Country
9.1.1 Middle East & Africa Muscarinic Acetylcholine Receptor M4 Sales and Market Share by Country (2015-2020)
9.1.2 Middle East & Africa Muscarinic Acetylcholine Receptor M4 Revenue and Market Share by Country (2015-2020)
9.2 Saudi Arabia Muscarinic Acetylcholine Receptor M4 Sales and Growth Rate (2015-2020)
9.3 Turkey Muscarinic Acetylcholine Receptor M4 Sales and Growth Rate (2015-2020)
9.4 Egypt Muscarinic Acetylcholine Receptor M4 Sales and Growth Rate (2015-2020)
9.5 South Africa Muscarinic Acetylcholine Receptor M4 Sales and Growth Rate (2015-2020)
10 Market Segment by Type
10.1 Global Muscarinic Acetylcholine Receptor M4 Sales and Market Share by Type (2015-2020)
10.2 Global Muscarinic Acetylcholine Receptor M4 Revenue and Market Share by Type (2015-2020)
10.3 Global Muscarinic Acetylcholine Receptor M4 Price by Type (2015-2020)
11 Global Muscarinic Acetylcholine Receptor M4 Market Segment by Application
11.1 Global Muscarinic Acetylcholine Receptor M4 Sales Market Share by Application (2015-2020)
11.2 Global Muscarinic Acetylcholine Receptor M4 Revenue Market Share by Application (2015-2020)
11.3 Global Muscarinic Acetylcholine Receptor M4 Price by Application (2015-2020)
12 Market Forecast
12.1 Global Muscarinic Acetylcholine Receptor M4 Sales, Revenue and Growth Rate (2021-2025)
12.2 Muscarinic Acetylcholine Receptor M4 Market Forecast by Regions (2021-2025)
12.2.1 North America Muscarinic Acetylcholine Receptor M4 Market Forecast (2021-2025)
12.2.2 Europe Muscarinic Acetylcholine Receptor M4 Market Forecast (2021-2025)
12.2.3 Asia-Pacific Muscarinic Acetylcholine Receptor M4 Market Forecast (2021-2025)
12.2.4 South America Muscarinic Acetylcholine Receptor M4 Market Forecast (2021-2025)
12.2.5 Middle East & Africa Muscarinic Acetylcholine Receptor M4 Market Forecast (2021-2025)
12.3 Muscarinic Acetylcholine Receptor M4 Market Forecast by Type (2021-2025)
12.3.1 Global Muscarinic Acetylcholine Receptor M4 Sales Forecast by Type (2021-2025)
12.3.2 Global Muscarinic Acetylcholine Receptor M4 Market Share Forecast by Type (2021-2025)
12.4 Muscarinic Acetylcholine Receptor M4 Market Forecast by Application (2021-2025)
12.4.1 Global Muscarinic Acetylcholine Receptor M4 Sales Forecast by Application (2021-2025)
12.4.2 Global Muscarinic Acetylcholine Receptor M4 Market Share Forecast by Application (2021-2025)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
15.3 Disclaimer
15.4 About US

...

【免責事項】
https://www.globalresearch.jp/disclaimer

★リサーチレポート[ 世界のムスカリン性アセチルコリン受容体M4市場2020:製造企業別、地域別、種類別、用途別、市場予測2025(Global Muscarinic Acetylcholine Receptor M4 Market 2020 by Manufacturers, Regions, Type and Application, Forecast to 2025)]についてメールでお問い合わせはこちらでお願いします。